Comparison of NEOVIST 370 INJ.(Iopromide 768.86mg) With Ultravist 370 INJ.(Iopromide 768.86mg) in Abdominal CT

Seoul National University

Status: Completed

Conditions: Abdominal CT

Treatments: Drug: Ultravist 370 INJ.(Iopromide 768.86mg); Drug: NEOVIST 370 INJ.(Iopromide 768.86mg)

Study type: Observational

Funder types: Other

Identifiers

NCT01654354

Neovist IIT

Details and patient eligibility

About

Comparison of NEOVIST 370 INJ.(Iopromide 768.86mg) with Ultravist 370 INJ.(Iopromide 768.86mg) in abdominal CT

Enrollment: 104 patients

Sex: All

Ages: 20 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Aged 20 to 75 years old.
• Subjects who need CT scan
• Subjects who are willing to participate in the study and to write the informed consent form.

Exclusion criteria

• Subjects with severe hepatopathy whose AST or ALT ≥ 1,000 IU/L, Subjects with liver cirrhosis whose AST or ALT ≥ UNL(upper normal limit) X 3
• Severe disorder of thyroid gland
• homocystinuria
• pregnant or breastfeeding female subjects, or female subjects with childbearing potential who are not willing to use proper contraception methods
• Participation in another clinical trial within 30days of enrollment into this study.